PMID- 34102461 OWN - NLM STAT- MEDLINE DCOM- 20220321 LR - 20221207 IS - 1873-6483 (Electronic) IS - 0740-5472 (Linking) VI - 132 DP - 2022 Jan TI - National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness. PG - 108504 LID - S0740-5472(21)00230-0 [pii] LID - 10.1016/j.jsat.2021.108504 [doi] AB - OBJECTIVE: People experiencing homelessness (PEH) have high rates of substance use, and homelessness may be an important driver of health disparities in the opioid overdose epidemic. However, few studies focus on homelessness among the opioid use disorder (OUD) treatment population. We examine national-level trends in substance use treatment admissions among PEH with OUD. METHODS: This study used data from first-time treatment admissions in the United States from the Treatment Episode Data Set: Admissions (TEDS-A) to examine characteristics and trends of adults experiencing homelessness who entered state-licensed substance use treatment programs for OUD from 2013 to 2017. We used chi-squared analyses to examine changes in characteristics of this population over time and logistic regression to assess characteristics associated with receipt of medications for opioid use disorder (MOUD) among PEH. RESULTS: Among all adults with OUD entering specialty treatment from 2013 to 2017, 12.5% reported experiencing homelessness. Compared to individuals not experiencing homelessness, PEH were more likely to be male, inject opioids, use cocaine or methamphetamine, and enter into residential detoxification treatment. PEH were less likely to enter outpatient treatment or receive MOUD. From 2013 to 2017, significant increases occurred in the proportion of PEH who had co-occurring psychiatric problems and used methamphetamines. Over time, treatment type shifted significantly from residential detoxification to outpatient treatment. Receipt of MOUD increased among PEH over time (13.7% to 25.2%), but lagged behind increases among individuals not experiencing homelessness. Among PEH, being older was associated with receiving MOUD, while concurrent methamphetamine use [adjusted odds ratio (AOR) 0.63; 95% CI 0.58, 0.69] and living in the southern United States (AOR 0.27; 95% CI 0.25, 0.30) were associated with not receiving MOUD. DISCUSSION: The proportion of PEH with OUD who receive medications as part of treatment increased over time, but three quarters of PEH entering treatment still do not receive this highest standard in evidence-based care. The sharp increase observed in concomitant methamphetamine use in this population is concerning and has implications for treatment. CI - Copyright (c) 2021 Elsevier Inc. All rights reserved. FAU - Han, Benjamin H AU - Han BH AD - Division of Geriatrics, Gerontology, and Palliative Care, University of California, San Diego School of Medicine, 9500 Gilman Dr, San Diego, CA 92161, United States of America. Electronic address: b2han@health.ucsd.edu. FAU - Doran, Kelly M AU - Doran KM AD - Department of Emergency Medicine, NYU School of Medicine, 550 First Avenue, New York, NY 10016, United States of America; Department of Population Health, NYU School of Medicine, 550 First Avenue, New York, NY 10016, United States of America. FAU - Krawczyk, Noa AU - Krawczyk N AD - Department of Population Health, NYU School of Medicine, 550 First Avenue, New York, NY 10016, United States of America. LA - eng GR - K23 DA039179/DA/NIDA NIH HHS/United States GR - K23 DA043651/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20210529 PL - United States TA - J Subst Abuse Treat JT - Journal of substance abuse treatment JID - 8500909 RN - 0 (Analgesics, Opioid) SB - IM MH - Adult MH - Ambulatory Care MH - Analgesics, Opioid/therapeutic use MH - Female MH - *Ill-Housed Persons MH - Humans MH - Male MH - *Opioid-Related Disorders/drug therapy/therapy MH - Residential Treatment MH - United States/epidemiology OTO - NOTNLM OT - Homelessness OT - Opioids OT - Substance use treatment EDAT- 2021/06/09 06:00 MHDA- 2022/03/22 06:00 CRDT- 2021/06/08 20:47 PHST- 2020/10/19 00:00 [received] PHST- 2021/04/05 00:00 [revised] PHST- 2021/05/21 00:00 [accepted] PHST- 2021/06/09 06:00 [pubmed] PHST- 2022/03/22 06:00 [medline] PHST- 2021/06/08 20:47 [entrez] AID - S0740-5472(21)00230-0 [pii] AID - 10.1016/j.jsat.2021.108504 [doi] PST - ppublish SO - J Subst Abuse Treat. 2022 Jan;132:108504. doi: 10.1016/j.jsat.2021.108504. Epub 2021 May 29.